We analyze polymyalgia rheumatica biomarkers, highlighting key study findings, regulatory updates, and test availability in major hospital systems.

We analyze polymyalgia rheumatica biomarkers, highlighting key study findings, regulatory updates, and test availability in major hospital systems.